Cas 847489-05-8,N-[3-(2-fluoro-4’-[1,2,3]triazol-1-ylmethylbiphenyl-4-yl)-2-oxo-oxazolidin-5-(S)-ylmethyl]acetamide

847489-05-8

Post Buying Request

Basic information

Product Name: N-[3-(2-fluoro-4’-[1,2,3]triazol-1-ylmethylbiphenyl-4-yl)-2-oxo-oxazolidin-5-(S)-ylmethyl]acetamide
Synonyms:
CAS NO:847489-05-8
Molecular Formula:
Molecular Weight: 409.42
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[3-(2-fluoro-4’-[1,2,3]triazol-1-ylmethylbiphenyl-4-yl)-2-oxo-oxazolidin-5-(S)-ylmethyl]acetamide(CAS DataBase Reference)
NIST Chemistry Reference: N-[3-(2-fluoro-4’-[1,2,3]triazol-1-ylmethylbiphenyl-4-yl)-2-oxo-oxazolidin-5-(S)-ylmethyl]acetamide(847489-05-8)
EPA Substance Registry System: N-[3-(2-fluoro-4’-[1,2,3]triazol-1-ylmethylbiphenyl-4-yl)-2-oxo-oxazolidin-5-(S)-ylmethyl]acetamide(847489-05-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 847489-05-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

847489-05-8 Suppliers

Recommended suppliers

847489-05-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 847489-05-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,7,4,8 and 9 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 847489-05:
(8*8)+(7*4)+(6*7)+(5*4)+(4*8)+(3*9)+(2*0)+(1*5)=218
218 % 10 = 8
So 847489-05-8 is a valid CAS Registry Number.

847489-05-8Upstream product

847490-51-1 C₂₄H₂₈FN₅O₃Si

847489-05-8Downstream Products

847489-05-8Relevant academic research and scientific papers

Design at the atomic level: Design of biaryloxazolidinones as potent orally active antibiotics

Zhou, Jiacheng,Bhattacharjee, Ashoke,Chen, Shili,Chen, Yi,Duffy, Erin,Farmer, Jay,Goldberg, Joel,Hanselmann, Roger,Ippolito, Joseph A.,Lou, Rongliang,Orbin, Alia,Oyelere, Ayomi,Salvino, Joe,Springer, Dane,Tran, Jennifer,Wang, Deping,Wu, Yusheng,Johnson, Graham

scheme or table, p. 6175 - 6178 (2009/06/30)

We have developed a first generation of hybrid sparsomycin-linezolid compounds into a new family of orally bioavailable biaryloxazolidinones that have activity against both linezolid-susceptible and -resistant Gram-positive bacteria as well as the fastidi

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 847489-05-8